Ambalal Sarabhai Enterprises Ltd.
BSE: 500009 | Sector: Health care |
NSE: AMBASARABH | ISIN Code: INE432A01017 |
BSE 16:01 | 30 Jan | 23.85 |
-0.70 (-2.85%) |
OPEN
24.95 |
HIGH
24.95 |
LOW
23.50 |
NSE 05:30 | 01 Jan | Ambalal Sarabhai Enterprises Ltd |
OPEN | 24.95 |
PREVIOUS CLOSE | 24.55 |
VOLUME | 114851 |
52-Week high | 44.60 |
52-Week low | 23.50 |
P/E | 36.69 |
Mkt Cap.(Rs cr) | 183 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Ambalal Sarabhai Enterprises Ltd. (AMBASARABH) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 1050.90 | 0.70 | 1071.90 | 789.75 | 252142.43 |
Divi's Lab. | 3369.35 | -0.48 | 4640.95 | 3197.00 | 89439.40 |
Cipla | 1037.50 | -0.91 | 1185.20 | 880.00 | 83741.81 |
Dr Reddy's Labs | 4331.45 | 0.30 | 4645.55 | 3655.00 | 72127.31 |
Apollo Hospitals | 4249.00 | 0.13 | 5015.45 | 3365.90 | 61092.12 |
Torrent Pharma. | 1545.05 | 0.47 | 1722.70 | 1242.50 | 52290.67 |
Abbott India | 20967.75 | -1.19 | 22481.80 | 15525.00 | 44556.47 |
Zydus Lifesci. | 427.75 | -0.58 | 458.60 | 319.40 | 43296.86 |
Max Healthcare | 439.85 | -3.36 | 482.50 | 306.00 | 42702.40 |
Alkem Lab | 3004.50 | 0.23 | 3720.00 | 2835.00 | 35918.80 |
Lupin | 732.25 | -1.34 | 922.50 | 583.05 | 33310.05 |
Biocon | 233.80 | -0.72 | 410.50 | 229.70 | 28070.03 |
Aurobindo Pharma | 411.60 | -1.12 | 730.00 | 409.20 | 24115.64 |
Syngene Intl. | 565.30 | -0.41 | 682.25 | 508.10 | 22692.84 |
Ipca Labs. | 854.00 | 0.40 | 1089.00 | 830.00 | 21665.98 |
Gland Pharma | 1311.90 | -3.33 | 3599.00 | 1307.05 | 21606.99 |
Glaxosmi. Pharma | 1257.00 | -0.36 | 1734.90 | 1256.15 | 21294.84 |
Fortis Health. | 276.25 | -1.44 | 324.80 | 219.80 | 20855.77 |
Laurus Labs | 341.85 | 0.00 | 626.00 | 337.25 | 18413.75 |
Pfizer | 3942.00 | -1.47 | 4800.00 | 3930.00 | 18034.65 |
Quick Links for Ambalal Sarabhai Enterprises:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices